FDA Adverse Event Injury Summary report: N

UNK XEN STENT

MDR report key: 15089424 · Received July 22, 2022

Report

Report Number
3011299751-2022-00128
Event Type
Injury
Date Received
July 22, 2022
Date of Event
January 4, 2022
Report Date
August 11, 2022
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IMPLANTATION NOTED BETWEEN (B)(6) 2016 AND (B)(6) 2020 ARTICLE CITATION: CAPPELLI F, CUTOLO CA,OLIVARI S, ET AL. "TRABECULECTOMYVERSUS XEN GEL IMPLANT FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA: A 3- YEAR RETROSPECTIVE ANALYSIS." BMJOPEN OPHTHALMOLOGY 2022, 7:E000830. DOI:10.1136/BMJOPHTH-2021-000830. FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Additional Manufacturer Narrative · 0

AWARE DATE [PARENT] WAS INITIALLY SENT AS (B)(6) 2022. THE CORRECTED INITIAL AWARE DATE [PARENT] SHOULD BE (B)(6) 2022.

Description of Event or Problem · 0

REPORTED EVENTS OF 6 EYES WITH CHOROIDAL DETACHMENTS, 1 EYE POSITIVE SEIDEL TEST, 2 EYES WITH HYPHEMA, 2 EYES REQUIRED ND:YAG LASER SURGICAL TREATMENT TO RESTORE PATENCY, NEEDLING WAS REQUIRED AN AVERAGE OF 2.7 TIMES, 1 EYE REQUIRED BLEB REVISION, AND 7 EYES REQUIRED TRABECULECTOMY WERE NOTED IN THE ARTICLE, "TRABECULECTOMY VERSUS XEN GEL IMPLANT FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA: A 3-YEAR RETROSPECTIVE ANALYSIS." BMJ OPEN OPHTHALMOLOGY (2022); VOLUME 7.

Description of Event or Problem · 0

REPORTED EVENTS OF 6 EYES WITH CHOROIDAL DETACHMENTS, 1 EYE POSITIVE SEIDEL TEST, 2 EYES WITH HYPHEMA, 2 EYES REQUIRED ND:YAG LASER SURGICAL TREATMENT TO RESTORE PATENCY, NEEDLING WAS REQUIRED AN AVERAGE OF 2.7 TIMES, 1 EYE REQUIRED BLEB REVISION, AND 7 EYES REQUIRED TRABECULECTOMY WERE NOTED IN THE ARTICLE, "TRABECULECTOMY VERSUS XEN GEL IMPLANT FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA: A 3-YEAR RETROSPECTIVE ANALYSIS." BMJ OPEN OPHTHALMOLOGY (2022); VOLUME 7.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
103117 UNK XEN STENT IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) NI

Patients

Seq Age Sex Outcome Treatment
1 73 YR Female Required Intervention